Search

everythinglearnresearchcommunity

for

Search:↓

Different genes are active in dogs' hair growth and skin, similar to humans, which helps understand dog skin and hair diseases and can relate to human conditions.

COVID-19 can cause temporary hair loss, often starting around 7-8 weeks after recovery, with factors like Vitamin D deficiency, other diseases, medication, and stress potentially contributing.

A woman had hair loss, nail changes, and skin peeling after a COVID-19 infection, which got better on their own.

Hair loss (telogen effluvium) cases rose during the pandemic, especially in Hispanic and non-White groups, and were linked to other health issues and COVID-19.

Only about 20% of women have hair loss after childbirth severe enough to be considered clinically significant.

Hair loss can cause scalp discomfort.

Low-dose oral minoxidil improved hair growth in most pediatric patients with mild side effects.

ALRV5XR significantly improves hair density in women with hair loss and is well-tolerated.

Eating too much or too little vitamin A can cause hair loss.

Poor sleep during the pandemic may increase stress and worsen hair loss conditions.

Taking vitamin D3 pills helped improve hair growth in women with a certain type of hair loss.

Heavy metals might contribute to hair loss in Telogen Effluvium.

Gamma-rays exposure during the resting phase of hair growth can damage hair regeneration and color in mice.

Trichoscopy is not specific for diagnosing telogen effluvium and both telogen effluvium and androgenetic alopecia often occur together.

Colostrum-derived exosomes can promote hair growth and may be a promising treatment for hair loss.

QR678 Neo® hair growth treatment is effective for hair loss caused by Covid-19.

Hair loss can happen after a fever caused by Rickettsia conorii infection.

Certain growth factors significantly affect hair loss in women with telogen effluvium.

Obese mice with a leptin gene mutation have a longer resting phase in their hair cycle, which may help understand certain hair loss conditions.

Hair loss in Telogen effluvium is often chronic, linked to stress, and lacks a confirmed treatment, but topical corticosteroids may be used.

A woman experienced temporary hair loss after taking albendazole, which resolved on its own within 3 months.

Hair loss can be an early sign of HIV infection.

Hair loss in a woman with eosinophilia-myalgia syndrome improved after stopping L-tryptophan and starting treatment.

COVID-19 can cause a temporary hair loss condition.

Some people in Saudi Arabia experienced hair loss after the COVID-19 vaccine, more often in women and those without prior hair loss.

COVID-19 may cause temporary hair loss due to direct damage to hair follicles, but it usually gets better on its own.

Injecting scalp tissue micrografts is a safe and effective treatment for hair loss after COVID-19.

Monocytes might be linked to hair loss after COVID-19.

COVID-19 and related stress may increase hair loss known as Telogen effluvium.